BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21493758)

  • 1. Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas.
    Thway K; Selfe J; Missiaglia E; Fisher C; Shipley J
    J Clin Pathol; 2011 Jul; 64(7):587-91. PubMed ID: 21493758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases.
    Chan ES; Pawel BR; Corao DA; Venneti S; Russo P; Santi M; Sullivan LM
    Pediatr Dev Pathol; 2013; 16(4):272-7. PubMed ID: 23530909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells.
    Thway K; Robertson D; Jones RL; Selfe J; Shipley J; Fisher C; Isacke CM
    Br J Cancer; 2016 Aug; 115(4):473-9. PubMed ID: 27434038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican 3: a novel marker in testicular germ cell tumors.
    Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
    Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
    Jin Z; Lahat G; Korchin B; Nguyen T; Zhu QS; Wang X; Lazar AJ; Trent J; Pollock RE; Lev D
    Clin Cancer Res; 2008 Aug; 14(16):5033-42. PubMed ID: 18698021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
    Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
    Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
    Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
    Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary embryonal spindle cell cardiac rhabdomyosarcoma: case report.
    Fraternali Orcioni G; Ravetti JL; Gaggero G; Bocca B; Bisceglia M
    Pathol Res Pract; 2010 May; 206(5):325-30. PubMed ID: 19577381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin isoform pattern expression: a tool for the diagnosis and biological characterization of human rhabdomyosarcoma.
    Clément S; Orlandi A; Bocchi L; Pizzolato G; Foschini MP; Eusebi V; Gabbiani G
    Virchows Arch; 2003 Jan; 442(1):31-8. PubMed ID: 12536312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
    Fadare O
    Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
    Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study.
    Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J
    Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
    Harms D
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
    Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
    Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.
    Michelagnoli MP; Burchill SA; Cullinane C; Selby PJ; Lewis IJ
    Med Pediatr Oncol; 2003 Jan; 40(1):1-8. PubMed ID: 12426678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
    Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
    Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression and cluster analysis of mesenchymal and neural stem cell-associated proteins in pediatric soft tissue sarcomas.
    Sadikovic B; Graham C; Ho M; Zielenska M; Somers GR
    Pediatr Dev Pathol; 2011; 14(4):259-72. PubMed ID: 21162641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy: retrospective review of clinical material.
    Sebire NJ; Ramsay AD; Levitt G; Malone M; Risdon RA
    Pediatr Dev Pathol; 2002; 5(6):579-86. PubMed ID: 12370769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.